Skip to main content
SpringerLink
Log in

M69 Osteoporose

  • Chapter
Bewegingsapparaat

  • 1176 Accesses

Zusammenfassung

De NHG-Standaard Osteoporose geeft richtlijnen voor de preventie, diagnostiek en therapie van osteoporose. Deze richtlijnen betreffen drie categoriee ¨n patie¨nten:

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatuur

  • Bij verwijzingen naar NHG-producten zoals NHG-Standaarden en Farmacotherapeutische Richtlijnen (FTR’en): zie http://nhg.artsennet.nl

  • Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, et al. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum 2001;44:202-211.

    CAS  PubMed  Google Scholar 

  • Albrand G, Munoz F, Sornay-Rendu E, DuBoeuf F, Delmas PD. Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study. Bone 2003;32:78-85.

    CAS  PubMed  Google Scholar 

  • Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.

    CAS  PubMed  Google Scholar 

  • Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427.

    CAS  PubMed  Google Scholar 

  • Beral V, Bull D, Reeves G; Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005;365:1543-1551.

    PubMed  Google Scholar 

  • Bikle DD. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis. Rheum Dis Clin North Am 1994;20:759-775.

    CAS  PubMed  Google Scholar 

  • Bischoff-Ferrari HA, Dawson-Hughes B, WillettWC, Staehelin HB, BazemoreMG, Zee RY, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999-2006.

    CAS  PubMed  Google Scholar 

  • Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996;348:1535-41.

    CAS  PubMed  Google Scholar 

  • Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 2000;85:4118-4124.

    CAS  PubMed  Google Scholar 

  • Bo-Linn GW, Davis GR, Buddrus DJ, Morawski SG, Santa AC, Fordtran JS. An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium. J Clin Invest 1984;73:640-647.

    CAS  PubMed  Google Scholar 

  • Bonaiuti D, Shea B, Iovine R, Negrini S, Robinson V, Kemper HC, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev 2002;3:CD000333.

    PubMed  Google Scholar 

  • Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, et al. Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 2004;350:1189-1199.

    CAS  PubMed  Google Scholar 

  • Brown JP, Kendler DL, McClung MR, Emkey RD, Adachi JD, Bolognese MA, et al. The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. Calcif Tissue Int 2002;71:103-111.

    CAS  PubMed  Google Scholar 

  • Brumsen C, Papapoulos SE, Lips P, Geelhoed-Duijvestijn PH, Hamdy NA, Landman JO, et al. Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extension. J Bone Miner Res 2002;17: 1057-1064.

    CAS  PubMed  Google Scholar 

  • Burger H, Van Daele PL, Grashuis K, Hofman A, Grobbee DE, Schutte HE, et al. Vertebral deformities and functional impairment in men and women. J Bone Miner Res 1997;12: 152-157.

    CAS  PubMed  Google Scholar 

  • Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-1642.

    CAS  PubMed  Google Scholar 

  • Chesnut CH 3rd, Silverman S, Andriano K, Genant H, Gimona A, Harris S, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 2000;109:267-276.

    CAS  PubMed  Google Scholar 

  • Clemmesen B, Ravn P, Zegels B, Taquet AN, Christiansen C, Reginster JY. A 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis. Osteoporos Int 1997;7:488-495.

    CAS  PubMed  Google Scholar 

  • Commissie Aanvullende Diagnostiek. Diagnostisch kompas 2003. Amstelveen: College voor Zorgverzekeringen, 2003.

    Google Scholar 

  • Commissie Farmaceutische Hulp. Farmacotherapeutisch Kompas 2005. Amstelveen: College voor Zorgverzekeringen, 2005.

    Google Scholar 

  • Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ III. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992;7:221-227.

    CAS  PubMed  Google Scholar 

  • Coupland C, Wood D, Cooper C. Physical inactivity is an independent risk factor for hip fracture in the elderly. J Epidemiol Community Health 1993;47:441-443.

    CAS  PubMed  Google Scholar 

  • Cranney A, Welch V, Adachi JD, Guyatt G, Krolicki N, Griffith L, et al. Etidronate for treating and preventing postmenopausal osteoporosis. Cochrane Database Syst Rev 2001; 3:CD003376.

    Google Scholar 

  • Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, et al. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 2002;23:508-516.

    CAS  PubMed  Google Scholar 

  • Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, et al. Risedronate for the prevention and treatment of postmenopausal osteoporosis. Cochrane Database Syst Rev 2003;4:CD004523.

    PubMed  Google Scholar 

  • Cranney A, Welch A, Adachi JD, Guyatt G, Krolicki N, Griffith L. Etidronate for treating and preventing postmenopausal osteoporosis. Cochrane Database Syst Rev 2004;2:CD.

    Google Scholar 

  • Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993;341:72-75.

    CAS  PubMed  Google Scholar 

  • Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995;332:767-773.

    CAS  PubMed  Google Scholar 

  • Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, et al. Endogenous ormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1998;339:733-738.

    CAS  PubMed  Google Scholar 

  • Cummings SR, Black O, Barrett-Conner E, Scott J, Wallace RB. Alendronate and fracture prevention. JAMA 1999; 282: 324-325.

    CAS  PubMed  Google Scholar 

  • D’Argent-Molina P, Favier F, Grandjean H, Baudoin C, Schott AM, Hausherr E, et al. Fallrelated factors and risk of hip fracture: the EPIDOS prospective study. Lancet 1996;348: 145-149.

    Google Scholar 

  • Davies MC, Hall ML, Jacobs HS. Bone mineral loss in young women with amenorrhea. BMJ 1990;301:790.

    CAS  PubMed  Google Scholar 

  • Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990;323:878-883.

    CAS  PubMed  Google Scholar 

  • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670.

    Google Scholar 

  • De Laet CE, Van Hout BA, Hofman A, Pols HA. Kosten wegens osteoporotische fracturen in Nederland: mogelijkheden voor kostenbeheersing. Ned Tijdschr Geneeskd 1996;140: 1684-1688.

    PubMed  Google Scholar 

  • De Laet CE, Van Hout BA, Burger H, Hofman A, Pols HA. Bone density and risk of hip fracture in men and women: cross sectional analysis. BMJ 1997;315:221-225.

    PubMed  Google Scholar 

  • Deyo RA, Diehl AK. Cancer as a cause of back pain: frequency, clinical presentation, and diagnostic strategies. J Gen Intern Med 1988;3:230-238.

    CAS  PubMed  Google Scholar 

  • Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about low back pain? JAMA 1992;268:760-765.

    CAS  PubMed  Google Scholar 

  • Diaz MN, O’Neill TW, Silman AJ. The influence of family history of hip fracture on the risk of vertebral deformity in men and women: the European Vertebral Osteoporosis Study. Bone 1997;20:145-9.

    CAS  PubMed  Google Scholar 

  • Elders PJ, Lips P, Netelenbos JC, Van Ginkel FC, Khoe E, Van der Vijgh WJ, et al. Longterm effect of calcium supplementation on bone loss in perimenopausal women. J Bone Miner Res 1994;9:963-70.

    CAS  PubMed  Google Scholar 

  • Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999;282:637-645.

    CAS  PubMed  Google Scholar 

  • Gallagher JC, Genant HK, Crans GG, Vargas SJ, Krege JH. Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures. J Clin Endocrinol Metab 2005;90:1583-1587.

    CAS  PubMed  Google Scholar 

  • Garton MJ, Robertson EM, Gilbert FJ, Gomersall L, Reid DM. Can radiologists detect osteopenia on plain radiographs? Clin Radiol 1994;49:118-122.

    CAS  PubMed  Google Scholar 

  • Geneesmiddeleninformatiecentrum van het Wetenschappelijk Instituut Nederlandse Apothekers (WINAp). Informatorium Medicamentorum 2004. Den Haag: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, 2004.

    Google Scholar 

  • Gezondheidsraad; Commissie Osteoporose. Preventie van aan osteoporose gerelateerde fracturen. Rijswijk: Gezondheidsraad, 1998.

    Google Scholar 

  • Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE, Cumming RG, Rowe BH. Interven tions for preventing falls in elderly people. Cochrane Database Syst Rev 2003;4: CD000340.

    PubMed  Google Scholar 

  • Gillespie LD. Preventing falls in elderly people. BMJ 2004;328:653-654.

    PubMed  Google Scholar 

  • Graafmans WC, Ooms ME, Bezemer PD, Bouter LM, Lips P. Different risk profiles for hip fractures and distal forearm fractures: a prospective study. Osteoporos Int 1996;6:427-431.

    CAS  PubMed  Google Scholar 

  • Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005;365:1621-1628.

    CAS  PubMed  Google Scholar 

  • Green AD, Colon-Emeric CS, Bastian L, Drake MT, Lyles KW. Does this woman have osteoporosis? JAMA 2004;292:2890-2900.

    CAS  PubMed  Google Scholar 

  • Greenspan SL, Myers ER, Maitland LA, Resnick NM, Hayes WC. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. JAMA 1994;271:128-133.

    CAS  PubMed  Google Scholar 

  • Grootjans-Geerts I, Wielders JPM. Pilotonderzoek naar hypovitaminose D bij ogenschijnlijk gezonde gesluierde Turkse vrouwen: ernstige vitamine-D-deficiëntie bij 82%. Ned Tijdschr Geneeskd 2002;146:1100-1101.

    CAS  PubMed  Google Scholar 

  • Gulekil B, Davies MC, Jacobs HS. Effect of treatment on established osteoporosis in young women with amenorrhoea. Clin Endocrinol 1994;41:275-281.

    Google Scholar 

  • Gutin B, Kasper MJ. Can vigorous exercise play a role in osteoporosis prevention? A review. Osteoporos Int 1992;2:55-69.

    CAS  PubMed  Google Scholar 

  • Haguenauer D, Welch B, Shea B, Tugwell P, Wells G. Fluoride for treating postmenopausal osteoporosis. Cochrane Database Syst Rev 2000;4:CD002825.

    PubMed  Google Scholar 

  • Hansen MA, Overgaard K, Riis BJ, Christiansen C. Potential risk factors for development of postmenopausal osteoporosis – examined over a 12-year period. Osteoporos Int 1991;1: 95-102.

    CAS  PubMed  Google Scholar 

  • Harvey JA, Zobitz MM, Pak CY. Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 1988;3:253-258.

    CAS  PubMed  Google Scholar 

  • Heaney RP, Smith KT, Recker RR, Hinders SM. Meal effects on calcium absorption. Am J Clin Nutr 1989;49:372-6.

    CAS  PubMed  Google Scholar 

  • Homik J, Cranney A, Shea B, Tugwell P, Wells G, Adachi R, Suarez-Almazor M. Bisphosphonates for steroid induced osteoporosis. Cochrane Database Syst Rev 2000;2: CD001347.

    PubMed  Google Scholar 

  • Huusko TM, Karppi P, Kautiainen H, Suominen H, Avikainen V, Sulkava R. Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture. Calcif Tissue Int 2002;71:478-484.

    CAS  PubMed  Google Scholar 

  • Jaglal SB, Kreiger N, Darlington G. Past and recent physical activity and risk of hip fracture. Am J Epidemiol 1993;138:107-118.

    CAS  PubMed  Google Scholar 

  • Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 2003;18:1932-41.

    CAS  PubMed  Google Scholar 

  • Kanis JA. Textbook of osteoporosis. Oxford: Blackwell Science, 1996.

    Google Scholar 

  • Katelaris AG, Cumming RG. Health status before and mortality after hip fracture. Am J Public Health 1996;86:557-560.

    CAS  PubMed  Google Scholar 

  • Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000;15:721-739.

    CAS  PubMed  Google Scholar 

  • Kwaliteitsinstituut voor de gezondheidszorg CBO. Osteoporose: tweede herziene richtlijn. Alphen a/d Rijn: Van Zuiden Communications, 2002.

    Google Scholar 

  • Lauritzen JB, Schwarz P, McNair P, Lund B, Transbol I. Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation. Osteoporos Int 1993;3:133-137.

    CAS  PubMed  Google Scholar 

  • Law MR, Wald NJ, Meade TW. Strategies for prevention of osteoporosis and hip fracture. BMJ 1991;303:453-459.

    CAS  PubMed  Google Scholar 

  • Lips P, Van Ginkel FC, Jongen MJ, Rubertus F, Van der Vijgh WJ, Netelenbos JC. Determinants of vitamin D status in patients with hip fracture and in elderly control subjects. Am J Clin Nutr 1987;46:1005-1010.

    CAS  PubMed  Google Scholar 

  • Lips P, Wiersinga A, Van Ginkel FC, Jongen MJ, Netelenbos JC, Hackeng WH, et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;67:644-50.

    CAS  PubMed  Google Scholar 

  • Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 1996;124:400-406.

    CAS  PubMed  Google Scholar 

  • Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 2004;89-90:611-614.

    CAS  PubMed  Google Scholar 

  • Longo DL. Plasma cell disorders. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Jameson JL (eds). Harrison’s principles of internal medicine. NewYork: McGraw-Hill, 2005;656-6561.

    Google Scholar 

  • Lufkin EG, Wahner HW, O’Fallon WM, Hodgson SF, Kotowicz MA, Lane AW, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992;117:1-9.

    CAS  PubMed  Google Scholar 

  • Lyritis GP, Ioannidis GV, Karachalios T, Roidis N, Kataxaki E, Papaioannou N, et al. Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study. Clin J Pain 1999;15:284-289.

    CAS  PubMed  Google Scholar 

  • McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004;350:2042-2049.

    CAS  PubMed  Google Scholar 

  • Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004;350:459-468.

    CAS  PubMed  Google Scholar 

  • Mortensen L, Charles P, Bekker PJ, Digennaro J, Johnston CC Jr. Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. J Clin Endocrinol Metab 1998;83:396-402.

    CAS  PubMed  Google Scholar 

  • Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.

    CAS  PubMed  Google Scholar 

  • Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 1998;128:793-800.

    CAS  PubMed  Google Scholar 

  • Nordin BE, Heaney RP. Calcium supplementation of the diet: justified by present evidence. BMJ 1990;300:1056-1060.

    CAS  PubMed  Google Scholar 

  • NVKG (Nederlandse Vereniging voor Klinische Geriatrie), Kwaliteitsinstituut voor de gezondheidszorg CBO. Richtlijn Preventie van valincidenten bij ouderen. Alphen a/d Rijn: Van Zuiden Communications, 2004.

    Google Scholar 

  • O’Loughlin JL, Robitaille Y, Boivin JF, Suissa S. Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993;137:342-354.

    PubMed  Google Scholar 

  • Oglesby AK, Minshall ME, Shen W, Xie S, Silverman SL. The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women. J Rheumatol 2003;30:1579-1583.

    PubMed  Google Scholar 

  • Ooms ME, Roos JC, Bezemer PD, Van der Vijgh WJ, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995;80:1052-1058.

    CAS  PubMed  Google Scholar 

  • Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000;343:604-610.

    CAS  PubMed  Google Scholar 

  • Parker MJ, Gillespie LD, Gillespie WJ. Hip protectors for preventing hip fractures in the elderly. Cochrane Database Syst Rev 2004;3:CD001255.

    PubMed  Google Scholar 

  • Pluijm SM, Graafmans WC, Bouter LM, Lips P. Ultrasound measurements for the prediction of osteoporotic fractures in elderly people. Osteoporos Int 1999;9:550-556.

    CAS  PubMed  Google Scholar 

  • PluijmSM, Tromp AM, Smit JH, Deeg DJ, Lips P. Consequences of vertebral deformities in older men and women. J Bone Miner Res 2000;15:1564-1572.

    CAS  PubMed  Google Scholar 

  • Porthouse J, Birks YF, Torgerson DJ, Cockayne S, Puffer S, Watt I. Risk factors for fracture in a UK population: a prospective cohort study. QJM 2004;97:569-574.

    CAS  PubMed  Google Scholar 

  • Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005;330:1003-1006.

    CAS  PubMed  Google Scholar 

  • Prior JC, Vigna YM, Schechter MT, Burgess AE. Spinal bone loss and ovulatory disturbances. N Engl J Med 1990;323:1221-1227.

    CAS  PubMed  Google Scholar 

  • Prismant. Landelijke LMR-informatie (2005). http://www.prismant.nl (>informatieproducten >ziekenhuisstatistieken>diagnosen>fracturen); geraadpleegd 31 januari 2005.

  • Recker RR. Calcium absorption and achlorhydria. N Engl J Med 1985;313:70-73.

    CAS  PubMed  Google Scholar 

  • Reginster JY, Christiansen C, Roux C, Fechtenbaum J, Rouillon A, Tou KP. Intermittent cyclic tiludronate in the treatment of osteoporosis. Osteoporos Int 2001;12:169-177.

    CAS  PubMed  Google Scholar 

  • Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, et al. Strontium ranelate reduces the risk of nonvertebral fractures in post-menopausal women with osteoporosis: tropos study. J Clin Endocrinol Metab 2005 [Epub].

    Google Scholar 

  • Reid DM, Adami S, Devogelaer JP, Chines AA. Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. Calcif Tissue Int 2001;69:242-247.

    CAS  PubMed  Google Scholar 

  • RIVM. Nationaal Kompas volksgezondheid (2005). http://www.nationaalkompas.nl; geraadpleegd 29 april 2005.

  • Rizzoli R, Greenspan SL, Bone G III, Schnitzer TJ, Watts NB, Adami S, et al. Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis. J Bone Miner Res 2002;17:1988-1996.

    CAS  PubMed  Google Scholar 

  • Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: prin cipal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321-333.

    CAS  PubMed  Google Scholar 

  • Roy DK, O’Neill TW, Finn JD, Lunt M, Silman AJ, Felsenberg D, et al. Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 2003;14:19-26.

    CAS  PubMed  Google Scholar 

  • Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L. Calcium supplementation on bone loss in postmenopausal women. Cochrane Database Syst Rev 2004;1:CD004526.

    PubMed  Google Scholar 

  • Sheikh MS, Santa Ana CA, Nicar MJ, Schiller LR, Fordtran JS. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987;317:532-536.

    CAS  PubMed  Google Scholar 

  • Silverman SL, Minshall ME, Shen W, Harper KD, Xie S. The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study. Arthritis Rheum 2001;44:2611-2619.

    CAS  PubMed  Google Scholar 

  • Simon JA, Lewiecki EM, Smith ME, Petruschke RA, Wang L, Palmisano JJ. Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study. Clin Ther 2002;24:1871-1886.

    CAS  PubMed  Google Scholar 

  • Sorensen OH, Crawford GM, Mulder H, Hosking DJ, Gennari C, Mellstrom D, et al. Longterm efficacy of risedronate: a 5-year placebo-controlled clinical experience. Bone 2003; 32:120-126.

    CAS  PubMed  Google Scholar 

  • Stel VS, Pluijm SM, Deeg DJ, Smit JH, Bouter LM, Lips P. A classification tree for predicting recurrent falling in community-dwelling older persons. J Am Geriatr Soc 2003;51: 1356-1364.

    PubMed  Google Scholar 

  • Tinetti ME, Mendes de Leon CF, Doucette JT, Baker DI. Fear of falling and fall-related efficacy in relationship to functioning among community-living elders. J Gerontol 1994; 49:M140-M147.

    CAS  PubMed  Google Scholar 

  • Tinetti ME, Doucette J, Claus E, Marottoli R. Risk factors for serious injury during falls by older persons in the community. J Am Geriatr Soc 1995;43:1214-21.

    CAS  PubMed  Google Scholar 

  • Tjeenk RM, Moerman MK, Kappetein AP, Kastelein GW, Breslau PJ. Goede resultaten na operatieve behandeling van proximale femurfracturen. Ned Tijdschr Geneeskd 1998;142: 1456-1459.

    CAS  PubMed  Google Scholar 

  • Tromp AM, Smit JH, Deeg DJ, Bouter LM, Lips P. Predictors for falls and fractures in the Longitudinal Aging Study Amsterdam. J Bone Miner Res 1998;13:1932-1939.

    CAS  PubMed  Google Scholar 

  • Tromp AM, Ooms ME, Popp-Snijders C, Roos JC, Lips P. Predictors of fractures in elderly women. Osteoporos Int 2000;11:134-140.

    CAS  PubMed  Google Scholar 

  • Ulrich U, Buck G, Lauritzen C. Osteopenia in primary and secondary amenorrhea. Horm Metab Res 1995;27:432.

    CAS  PubMed  Google Scholar 

  • Van Beresteijn EC, Van ’t Hof MA, Schaafsma G, De Waard H, Duursma SA. Habitual dietary calcium intake and cortical bone loss in perimenopausal women: a longitudinal study. Calcif Tissue Int 1990;47:338-344.

    PubMed  Google Scholar 

  • Van den Bergh JPW, Smals AGH, Schweitzer DH, Hermus ARMM. Ultrageluidsmetingen van de calcaneus: een veelbelovende methode om osteoporotische fracturen te voorspellen. Ned Tijdschr Geneeskd 2001;145:1105-1109.

    PubMed  Google Scholar 

  • Van den Hoogen HM, Koes BW, Van Eijk JT, Bouter LM. On the accuracy of history, physical examination, and erythrocyte sedimentation rate in diagnosing low back pain in general practice. A criteria-based review of the literature. Spine 1995;20:318-27.

    PubMed  Google Scholar 

  • Van der Linden MW, Westert GP, De Bakker DH, Schellevis FG. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk: klachten en aandoeningen in de bevolking en in de huisartspraktijk. Utrecht/Bilthoven: NIVEL/RIVM, 2004.

    Google Scholar 

  • Van der Klift M, De Laet CE, McCloskey EV, Johnell O, Kanis JA, Hofman A, et al. Risk factors for incident vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 2004;19:1172-80.

    PubMed  Google Scholar 

  • Van de Voorde M, Dequeker J, Geusens P. Effect of one late evening dose of calcium on bone resorption in postmenopausal women. In: Christiansen C, Overgaard K (eds). Osteoporosis 1990. Kopenhagen: Osteopress, 1990:1192-1193.

    Google Scholar 

  • Van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, Van der Klift, M, De Jonge R, Lindemans J, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350:2033-41.

    PubMed  Google Scholar 

  • Van Meurs JB, Uitterlinden AG. Homocysteine and fracture prevention. JAMA 2005;293: 1121-1122.

    PubMed  Google Scholar 

  • Van Schoor NM, Smit JH, Twisk JW, Bouter LM, Lips P. Prevention of hip fractures by external hip protectors: a randomized controlled trial. JAMA 2003;289:1957-62.

    PubMed  Google Scholar 

  • Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.

    PubMed  Google Scholar 

  • Van Staa TP, Leufkens HG, Cooper C. Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int 2002a;13:624-9.

    Google Scholar 

  • Van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002b;13:777-87.

    Google Scholar 

  • Vellas BJ, Wayne SJ, Romero LJ, Baumgartner RN, Garry PJ. Fear of falling and restriction of mobility in elderly fallers. Age Ageing 1997;26:189-193.

    CAS  PubMed  Google Scholar 

  • Wallach S, Cohen S, Reid DM, Hughes RA, Hosking DJ, Laan RF, et al. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 2000;67:277-285.

    CAS  PubMed  Google Scholar 

  • WHO. Assessment of osteoporotic fracture risk and its role in screening for postmenopausal women. Genève: WHO Technical Reports Series, 1994.

    Google Scholar 

Download references

Authors
  1. Joost Blijham
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Joost Blijham

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Bohn Stafleu van Loghum, onderdeel van Springer Media

About this chapter

Cite this chapter

Blijham, J. (2010). M69 Osteoporose. In: Blijham, J. (eds) Bewegingsapparaat. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-8460-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-90-313-8460-0_9

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-313-8459-4

  • Online ISBN: 978-90-313-8460-0

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation